Congressmembers Langworthy, Schrier Introduce Bipartisan Bill to Lower Prescription Drug Costs by Expanding Access to Biosimilars
require additional clinical studies whenever they are scientifically warranted. "Americans deserve access to safe, effective, and more affordable